|
1
|
Young LS and Dawson CW: Epstein-Barr virus
and nasopharyngeal carcinoma. Chin J Cancer. 33:581–590.
2014.PubMed/NCBI
|
|
2
|
Busson P, Keryer C, Ooka T and Corbex M:
EBV-associated nasopharyngeal carcinomas: From epidemiology to
virustargeting strategies. Trends Microbiol. 12:356–360. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Tao Q, Young LS, Woodman CB and Murray PG:
Epstein-Barr virus (EBV) and its associated human cancers -
genetics, epigenetics, pathobiology and novel therapeutics. Front
Biosci. 11:2672–2713. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lo KW, Teo PM, Hui AB, To KF, Tsang YS,
Chan SY, Mak KF, Lee JC and Huang DP: High resolution allelotype of
microdissected primary nasopharyngeal carcinoma. Cancer Res.
60:3348–3353. 2000.PubMed/NCBI
|
|
5
|
Shao J, Li Y, Wu Q, Liang X, Yu X, Huang
L, Hou J, Huang X, Ernberg I, Hu LF, et al: High frequency loss of
heterozygosity on the long arms of chromosomes 13 and 14 in
nasopharyngeal carcinoma in Southern China. Chin Med J.
115:571–575. 2002.PubMed/NCBI
|
|
6
|
Luzi P, Rafi MA and Wenger DA: Structure
and organization of the human galactocerebrosidase (GALC) gene.
Genomics. 26:407–409. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kwong J, Lo KW, To KF, Teo PM, Johnson PJ
and Huang DP: Promoter hypermethylation of multiple genes in
nasopharyngeal carcinoma. Clin Cancer Res. 8:131–137.
2002.PubMed/NCBI
|
|
8
|
Tong JH, Tsang RK, Lo KW, Woo JK, Kwong J,
Chan MW, Chang AR, van Hasselt CA, Huang DP and To KF: Quantitative
Epstein-Barr virus DNA analysis and detection of gene promoter
hypermethylation in nasopharyngeal (NP) brushing samples from
patients with NP carcinoma. Clin Cancer Res. 8:2612–2619.
2002.PubMed/NCBI
|
|
9
|
Challouf S, Ziadi S, Zaghdoudi R, Ksiaa F,
Ben Gacem R and Trimeche M: Patterns of aberrant DNA
hypermethylation in nasopharyngeal carcinoma in Tunisian patients.
Clin Chim Acta. 413:795–802. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Tong JH, Ng DC, Chau SL, So KK, Leung PP,
Lee TL, Lung RW, Chan MW, Chan AW, Lo KW, et al: Putative
tumour-suppressor gene DAB2 is frequently down regulated by
promoter hypermethylation in nasopharyngeal carcinoma. BMC Cancer.
10:2532010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Bodoor K, Haddad Y, Alkhateeb A, Al-Abbadi
A, Dowairi M, Magableh A, Bsoul N and Ghabkari A: DNA
hypermethylation of cell cycle (p15 and p16) and apoptotic (p14,
p53, DAPK and TMS1) genes in peripheral blood of leukemia patients.
Asian Pac J Cancer Prev. 15:75–84. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Park JY: Promoter hypermethylation as a
biomarker in prostate adenocarcinoma. Methods Mol Biol.
1238:607–625. 2015. View Article : Google Scholar
|
|
13
|
Wang HL, Zhou PY, Liu P and Zhang Y: Role
of p16 gene promoter methylation in gastric carcinogenesis: A
meta-analysis. Mol Biol Rep. 41:4481–4492. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Gloss BS, Patterson KI, Barton CA,
Gonzalez M, Scurry JP, Hacker NF, Sutherland RL, O'Brien PM and
Clark SJ: Integrative genome-wide expression and promoter DNA
methylation profiling identifies a potential novel panel of ovarian
cancer epigenetic biomarkers. Cancer Lett. 318:76–85. 2012.
View Article : Google Scholar
|
|
15
|
Wei KR, Xu Y, Liu J, Zhang WJ and Liang
ZH: Histopathological classification of nasopharyngeal carcinoma.
Asian Pac J Cancer Prev. 12:1141–1147. 2011.PubMed/NCBI
|
|
16
|
Görögh T, Rudert H, Lippert BM,
Gottschlich S, Maune S, Heidorn K, Maass J, Hoffmann M, Meyer JE,
Rathcke IO, et al: Transcriptional repression of the human
galactocerebrosidase gene in squamous cell carcinomas of the
larynx. Int J Cancer. 83:750–754. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kaneda A, Matsusaka K, Aburatani H and
Fukayama M: Epstein-Barr virus infection as an epigenetic driver of
tumorigenesis. Cancer Res. 72:3445–3450. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Matsusaka K, Kaneda A, Nagae G, Ushiku T,
Kikuchi Y, Hino R, Uozaki H, Seto Y, Takada K, Aburatani H, et al:
Classification of Epstein-Barr virus-positive gastric cancers by
definition of DNA methylation epigenotypes. Cancer Res.
71:7187–7197. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Fukayama M, Hino R and Uozaki H:
Epstein-Barr virus and gastric carcinoma: Virus-host interactions
leading to carcinoma. Cancer Sci. 99:1726–1733. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Owczarek TB, Suchanski J, Pula B, Kmiecik
AM, Chadalski M, Jethon A, Dziegiel P and Ugorski M:
Galactosylceramide affects tumorigenic and metastatic properties of
breast cancer cells as an anti-apoptotic molecule. PLoS One.
8:e841912013. View Article : Google Scholar
|
|
21
|
Beier UH and Görögh T: Implications of
galactocerebrosidase and galactosylcerebroside metabolism in cancer
cells. Int J Cancer. 115:6–10. 2005. View Article : Google Scholar : PubMed/NCBI
|
